12.2 Mevalonate kinase deficiency: Impaired isoprenoid synthesis induces IL-1beta production via activation of Rac1
Saved in:
Main Authors: | Kuijk LM (Author), Frenkel J (Author), Waterham HR (Author), Koster J (Author), Coffer PJ (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2008-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interleukin-1 antagonists in Mevalonate Kinase Deficiency
by: Hachulla E, et al.
Published: (2011) -
Tocilizumab for the Treatment of Mevalonate Kinase Deficiency
by: Nadia K. Rafiq, et al.
Published: (2018) -
The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency
by: Jerold Jeyaratnam, et al.
Published: (2022) -
Serum beta‐defensin‐2 is a biomarker for psoriasis but not subclinical atherosclerosis: Role of IL17a, PI‐3 kinase and Rac1
by: Carla J. Pantoja, et al.
Published: (2024) -
Efficacy of Anakinra Treatment in two Moroccan Patients With Mevalonate Kinase Deficiency
by: Manal Souali, et al.
Published: (2023)